
Ijeoma Isiadinso MD MPH FACC FASNC
Preventive Cardiology
Associate Professor of Medicine Director, Center for Heart Disease Prevention Emory University School of Medicine
Join to View Full Profile
Emory Clinic1365 Clifton Road, NeAtlanta, GA 30322
Phone+1 404-778-2746
Dr. Isiadinso is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ijeoma Isiadinso is a cardiologist based in Atlanta, GA, specializing in preventive cardiology. She completed her medical education at Drexel University College of Medicine in 2003 and underwent residency and fellowship training in internal medicine and cardiovascular disease at Temple University Hospital. Additionally, she holds an MPH degree. Dr. Isiadinso is experienced in general cardiology, preventive cardiology, cardio-rheumatology, and women’s heart disease. Her research work is published in esteemed journals, focusing on topics like lipoprotein(a) and cardiovascular complications, with multiple citations by other scientific publications. She is a Fellow of the American Society of Nuclear Cardiology and has earned several CMS Meaningful Use Certifications.
Education & Training
Temple University HospitalFellowship, Cardiovascular Disease, 2007 - 2010
Temple University HospitalResidency, Internal Medicine, 2003 - 2006
Drexel University College of MedicineClass of 2003
Drexel University School of Public Health MPH, Dual degree MD/MPH, 1998 - 2003
Certifications & Licensure
GA State Medical License 2010 - 2027
NY State Medical License 2025 - 2026
PA State Medical License 2003 - 2026
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FASNC) American Society of Nuclear Cardiology
- CMS Meaningful Use Stage 2 Certification FirstNet (Clinical), Cerner Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage 2 Certification HealtheLife and PowerChart, Cerner Corporation, 2013, 2015-2017
Publications & Presentations
PubMed
- From identification to implementation: A narrative review of strategies to close the implementation gap in patients with familial hypercholesterolemia.Abhilash Suresh, Sai Sripad Kodukula, Shoshana Bardach, Allison W Peng, Francoise A Marvel
Journal of Clinical Lipidology. 2026-06-02 - 7 citations2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Asso..., Roger S Blumenthal, Pamela B Morris, Mario Gaudino, Heather M Johnson
Circulation. 2026-04-28 - Hypertension in Women Across the Life Cycle: Unique Aspects and Challenges.Rachel M Bond, Vikramjit Purewal, Natalie Cameron, Kardie Tobb, Demilade Adedinsewo
Current Hypertension Reports. 2026-02-20
Authored Content
- Hypertension Across a Woman’s Life CycleApril 2018
- Hypertension Across a Woman’s Life CycleApril 2018
Press Mentions
ACCEL Lite: The Role of Prevention During and After ReproductionSeptember 23rd, 2025
Feature | Serving A Unique Population: Caring for the Cardio-Rheumatology PatientAugust 14th, 2020
Family Heart Foundation Discusses the Hidden Heart Risk Impacting 1 in 5 People with YourUpdateTVMarch 31st, 2026
Committees
- Co-chair/Member, Women in Preventive Cardiology 2022 - Present
Research History
- Site Co-investigatorACCLAIM-Lp (a): a Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults with Elevated Lipoprotein (a)2024 - Present
- Site PIHORIZON (a Randomized, Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering with TQJ230 on Major Cardiovascular Events in Patients with Established Cardiovascular Disease) study2021 - Present
- Co-investigatorCASCADE FH Registry2020 - Present
- Site PIWARRIOR (Women’s Ischemia Trial to Reduce Events in Non-Obstructive CAD) study2021 - 2025
Professional Memberships
- Member
- Member
- Member
- Member
- American Society of Preventive CardiologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









